HEMATOPOIESIS In hematopoietic cells in vertebrates, the Notch pathway appears to serve as a means to ensure that selected lineage commitment events proceed in a binary manner. In central lymphoid organs such as the bone marrow and thymus, the decision to become a T cell rather than a B cell requires signaling via Notch1. Two distinct B-lymphocyte lineages develop in the spleen. ---------------------------------------------------------------------------------------------------------------- 
Comment on Maillard et al, page 1696

A mastermind revealed ----------------------------------------------------------------------------------------------------------------
Shiv
Sharpening therapeutic strategy in AL amyloidosis
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Advances in AL amyloidosis: improved quality of life for patients responding to stem cell transplantation and honed patient selection and prognostication using sensitive cardiac biomarkers. P rimary systemic amyloidosis (AL) is a complex multisystem disease that demands both clinical alertness for prompt recognition and a personalized therapeutic strategy. The hematologic complete response rate, improvement of target organ dysfunction, and survival after high-dose therapy followed by autologous peripheral blood stem cell transplantation (PBSCT) have been reported in several nonrandomized trials including approximately 500 treated patients. Seldin and colleagues now report that PBSCT also produces measurable and sustained improvement in healthrelated quality of life (QOL), particularly in patients who achieve hematologic complete response (CR). The results attained with PBSCT in selected AL patients, namely high rate of CR, improvement of organ system dysfunction and QOL, and long-term For personal use only. by on February 7, 2008. www.bloodjournal.org From
